A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.
from Reuters: Health News https://reut.rs/2DO3Zee
via IFTTT
from Reuters: Health News https://reut.rs/2DO3Zee
via IFTTT
Post a Comment